Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5687431 | The Journal of Urology | 2017 | 41 Pages |
Abstract
Fluorescent cystoscopy was associated with a reduced risk of bladder cancer recurrence vs white light cystoscopy. However, additional trials that adequately guard against performance bias are needed to confirm these findings. Fluorescent cystoscopy with hexaminolevulinic acid may be associated with a decreased risk of progression, but more studies with long-term followup are needed to better understand the effects of the photosensitizer used on progression.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Roger Chou, Shelley Selph, David I. Buckley, Rongwei Fu, Jessica C. Griffin, Sara Grusing, John L. Gore,